What is Novus Diagnostics?
Novus Diagnostics operates at the intersection of clinical precision and patient-centric care. The company specializes in developing advanced diagnostic solutions designed to provide clinicians with timely, actionable information during the critical early stages of infection. By focusing on the intersection of diagnostic accuracy and rapid turnaround, Novus Diagnostics addresses a significant gap in current clinical workflows, effectively positioning itself as a vital partner for healthcare providers seeking to improve patient outcomes through data-driven intervention.
How much funding has Novus Diagnostics raised?
Novus Diagnostics has raised a total of $4.7M across 1 funding round:
Private Equity
$4.7M
Private Equity (2025): $4.7M with participation from BVP Investments, Trinity Biotech, and Irrus Investments
Key Investors in Novus Diagnostics
BVP Investments
BVP is an Irish investment firm specializing in high-impact ventures across health, climate, and emerging technology, providing flexible capital solutions from seed to growth stages.
Trinity Biotech
A commercial-stage biotechnology firm focused on diagnostic systems and wearable biosensors, with a global distribution network spanning over 75 countries.
Irrus Investments
A prominent Irish business angel network that provides mentorship and capital to innovative teams within the life sciences, medical device, and digital healthcare sectors.
What's next for Novus Diagnostics?
Following this major enterprise-level funding, Novus Diagnostics is expected to prioritize the scaling of its diagnostic platforms and the expansion of its clinical footprint. The strategic roadmap likely includes the refinement of its core diagnostic technologies and the pursuit of broader market penetration in both domestic and international clinical settings. As the company transitions into this next phase of growth, the focus will remain on maintaining high-accuracy standards while navigating the complexities of the global diagnostic market. The backing from seasoned investors provides not only the necessary financial runway but also the industry expertise required to navigate regulatory landscapes and accelerate product adoption in high-acuity care environments.
See full Novus Diagnostics company page
